` ANCR (Animalcare Group PLC) vs FTSE All Share Index Comparison - Alpha Spread

ANCR
vs
F
FTSE All Share Index

Over the past 12 months, ANCR has significantly outperformed FTSE All Share Index, delivering a return of +47% compared to the FTSE All Share Index's 0% growth.

Stocks Performance
ANCR vs FTSE All Share Index

Loading
ANCR
FTSE All Share Index
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
ANCR vs FTSE All Share Index

Loading
ANCR
FTSE All Share Index
Difference
www.alphaspread.com

Performance By Year
ANCR vs FTSE All Share Index

Loading
ANCR
FTSE All Share Index
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Animalcare Group PLC vs Peers

FTSE All Share Index
ANCR
JEF
JNJ
4312
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Animalcare Group PLC
Glance View

Market Cap
229.9m GBX
Industry
Pharmaceuticals

Animalcare Group Plc engages in the development, sale, and supply of generic veterinary medicines and animal identification products. The company is headquartered in Ripon, North Yorkshire. The company went IPO on 2008-01-15. The firm is focused on developing and commercializing prescription and over-the-counter pharmaceutical products. The firm operates in three categories within the veterinary market, which includes Companion Animals, Equine and Production Animals. The company manages international supply chain, including specialist veterinary wholesalers and distributors. The firm develops, supplies and markets products and services to the veterinary profession. The company focuses on therapeutic areas, which includes pain management, dermatology and anti-infectives. The Company’s product pipeline is Daxocox, which is a differentiated COX-2 inhibitor for the treatment of chronic pain in dogs.

ANCR Intrinsic Value
222.44 GBX
Overvaluation 33%
Intrinsic Value
Price GBX333
Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett